跳至主要内容
临床试验/IRCT20220516054874N2
IRCT20220516054874N2招募中2 期

Evaluation of the effectiveness of Gabapentin on the hs-CRP level in patients with non ST-elevation myocardial infarction

Mashhad University of Medical Sciences0 个研究点目标入组 68 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients with non-ST-elevation MI according to the American College of Heart criteria
  • Consent to admission to the study
  • Age more than 18 years old
  • No use of alprazolam and opioids in the admission
  • No kidney failure under hemodialysis
  • No kidney failure and GFR<30
  • No thrombocytopenia
  • No severe liver failure with liver enzymes three times more than normal
  • No treatment with corticosteroids or immunosuppressive drugs
  • No treatment with diltiazem or verapamil
  • No history or prone to suicide
  • No previous treatment with gabapentin
  • Not engaging in sensitive jobs such as driving, piloting, police

排除标准

  • Lack of consent to continue the study

研究者

相似试验